28/10/2021

Arginine methylation and ubiquitylation crosstalk controls DNA end resection and homologous recombination repair

María Pilar Sánchez-Bailón — Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch [Berlin, Germany]

04/11/2021

Tumor-specific pathways of therapy resistance in ALK-rearranged lymphoma

Roberto Chiarle — Harvard Medical School [Boston, USA]

11/11/2021

Insights into KRAS biology to identify novel therapeutic strategies for cancer

Chiara Ambrogio — Molecular Biotechnology Center (MBC) / University of Torino [Torino, Italy]

18/11/2021

High-risk cutaneous squamous cell carcinoma: our contributions to the current understanding and research priorities

Javier Cañueto Álvarez — Hospital Universitario de Salamanca, IBSAL

25/11/2021

Intracellular traffic of LAT and its role in T cell activation

Claire Hivroz — Institut Curie, [Paris, France]

02/12/2021

Illuminating the beginning of life

Melina Schuh — Max Planck Institute for Biophysical Chemistry, Göttingen Germany

09/12/2021

Protein bombs and liquid adhesions in immune cell mediated killing in cancer and infection

Michael Dustin — University of Oxford

16/12/2021

Mechanisms of gene regulation after fertilization: from transcription to decay

Antonio Giráldez — Yale University School of Medicine.

21/10/2021

Insights into the biological determinants of clonal evolution and therapeutic vulnerabilities of del(11q) chronic lymphocytic leukemia

Miguel Quijada Álamo — Centro de Investigación del Cáncer, CIC-IBMCC

14/10/2021

Evolutionary dynamics of human cancers

Trevor Graham — Cancer Research UK Barts Centre / Queen Mary University of London

07/10/2021

Targeting RAS-PI3K signaling to re-educate the stroma of RAS mutant lung cancers

Esther Castellano — Centro de Investigación del Cáncer, CIC-IBMCC

01/07/2021

Role of RRAS2 as an oncogenic driver

Laura Clavaín — Centro de Investigación del Cáncer (CIC-IBMCC)